Abstract
Most of the biological actions of insulin-like growth factor I (IGF-I)/somatomedin C are initiated by its binding to the IGF-I receptor, a heterotetrameric glycoprotein structurally related to the insulin receptor1. The presence of IGF-I receptors in most body tissues suggests that it mediates many different effects. Indeed, IGF-I has been shown to be involved not only in endocrine functions, such as the mediation of growth hormone’s effect on longitudinal growth, but it is also involved in many autocrine/paracrine systems at the local tissue level2,3. These biological actions include both short-term, metabolic effects (similar in nature to those stimulated by insulin) as well as long term, growth promoting actions. It is not surprising then, that the IGF- I receptor should be able to respond to various tissue — and development- specific stimuli. To study the expression of the IGF-I receptor gene in both physiological and pathological conditions in a convenient animal model, we undertook the cloning of rat IGF-I receptor cDNAs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Rechler, M.M., and Nissley, S.P., The nature and regulation of the receptors for insulin-like growth factors, Ann. Rev. Physiol. 47: 425 (1985).
Daughaday, W.H., and Rotwein, P., Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations, Endocrine Rev. 10: 68 (1989).
D–Ercole, A.J., Stiles, A.D., and Underwood, LE., Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanism of action, Proc. Nat. Acad. Sci. USA 81:935 (1984).
Ullrich, A., Gray, A., Tarn, A.W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., LeBon, T., Kathuria, S., Chen, E., Jacobs, S., Francke, U., Ramachandran, J., and Fujita-Yamaguchi, Y., Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity, EMBO J. 5: 2503 (1986).
Zilberstein, J., Chou, J.Y., Lowe, Jr., W.L., Shen-Orr, Z., Roberts, Jr., C.T., Leroith, and Catt, K.J., Expression of insulin-like growth factor-I and its receptor by SV40-transformed rat granulosa cells, Mol. Endocrinol. 3: 1488 (1989).
Werner, H., Woloschak, M., Adamo, M., Shen-Orr, Z., Roberts, Jr., C.T., and Leroith, D, Developmental regulation of the rat insulin-like growth factor I receptor gene, Proc. Natl. Acad. Sci. USA 86: 7451 (1989).
Bassas, L., DePablo, F., Lesniak, M.A., and Roth, J., Ontogeny of receptors for insulin-like peptides in chick embryo tissues: early dominance of insulin-like growth factor over insulin receptors in brain, Endocrinol. 117: 2321 (1985).
Pomerance, M., Gavaret, J-M., Jacquemin, C., Matricon, C., Toru-Delbauffe, D., and Pierre, M., Insulin and insulin-like growth factor I receptors during postnatal development of rat brain, Develop. Brain Res. 42:77 (1988).
Alexandrides, T., Moses, A.C., and Smith, R.J., Developmental expression of receptors for insulin, insulinlike growth factor I (IGF-I), and IGF-II in rat skeletal muscle, Endocrinol. 124: 1064 (1989).
Conti, F.G., Striker, L.J., Elliot, S.J., Andreani, D., and Striker, G.E., Synthesis and release of insulin-like growth factor I by mesangial cells in culture, Am. J. Physiol. 255:F1214 (1988).
Lajara, R., Rotwein, P., Bortz, J.D., Hansen, V.A., Sadow, J.L., Betts, C.R., Rogers, S.A., and Hammerman, M.R., Dual regulation of insulin-like growth factor I expression during renal hypertrophy, Am. J. Physiol. 257:F252 (1989).
Werner, H., Shen-Orr, Z.,Stannard, B., Burguera, B., Roberts, Jr., C.T., and Leroith,Experimental diabetes increases insulin-like growth factor I and II receptor concentration and gene expression in the kidney, Diabetes, in press (1990).
Lowe, Jr., W.L.,Adamo,Werner, H., Roberts, Jr., C.T.,and Leroith,Regulation by fasting of rat insulin-like growth factor I and its receptor, J. Clin. Invest. 84: 619 (1989).
Werner, H., Stannard, B., Bach, M.A., Leroith, D., and Roberts, Jr., C.T., Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene, Biochem. Biophys. Res. Comm. 169: 1021 (1990).
Smale, S.T., and Baltimore, D., The “initiator” as a transcription control element, Cell 57:103 (1989).
Kadonaga, J.T., and Tjian, R., Affinity purification of sequence-specific DNA binding proteins, Proc. Natl. Acad. Sci. USA 83: 5889 (1986).
Kageyama, R., Merlino, G.T., and Pastan, I., Nuclear factor ETF specifically stimulates transcription from promoters without a TATA box, J. Biol. Chem. 264: 15508 (1989) .
Roesler, W.J., Vandenbark, G.R., and Hanson, R.W., Cyclic AMP and the induction of eukaryotic gene transcription, J. Biol. Chem. 263: 9063 (1988).
Araki, E., Shimada, F., Uzawa, H., Mori, M., and Ebina, Y., Characterization of the promoter region of the human insulin receptor gene, J. Biol. Chem. 262: 16186 (1987).
Seino, S., Seino, M., Nishi, S., and Bell, G.I., Structure of the human insulin receptor gene and characterization of its promoter, Proc. Natl. Acad. Sci. USA 86:114 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Werner, H., Stannard, B., Bach, M.A., Roberts, C.T., LeRoith, D. (1991). Regulation of Insulin-Like Growth Factor I Receptor Gene Expression in Normal and Pathological States. In: Raizada, M.K., LeRoith, D. (eds) Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. Advances in Experimental Medicine and Biology, vol 293. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5949-4_24
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5949-4_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5951-7
Online ISBN: 978-1-4684-5949-4
eBook Packages: Springer Book Archive